Evidence map›Paper›PMID 36913102›Full record

ArticleBiotechnology letters2023

Inactivation of SARS-CoV-2 variants by nitrogen-doped titanium dioxide loaded with metals as visible-light photocatalysts.

Takashi Matsuyama, Shu Saeki, Satoru Kosaka, Yoriko Matsuoka, Yoshifumi Aoki, Yasushi Itoh, Takao Imaeda

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biotechnology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Takashi MatsuyamaToyota Central Research and Development Laboratories Incorporated, Nagakute, 480-1192, Japan. e1215@mosk.tytlabs.co.jp.ORCID http://orcid.org/0000-0001-7834-9358
Shu SaekiToyota Central Research and Development Laboratories Incorporated, Nagakute, 480-1192, Japan.
Satoru KosakaToyota Central Research and Development Laboratories Incorporated, Nagakute, 480-1192, Japan.
Yoriko MatsuokaToyota Central Research and Development Laboratories Incorporated, Nagakute, 480-1192, Japan.
Yoshifumi AokiToyota Central Research and Development Laboratories Incorporated, Nagakute, 480-1192, Japan.
Yasushi ItohShiga University of Medical Science, Otsu, 520-2192, Japan.
Takao ImaedaToyota Central Research and Development Laboratories Incorporated, Nagakute, 480-1192, Japan.
Toyota Central Research and Development Laboratories (Japan) · JPShiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe examined the inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by a nitrogen-doped titanium dioxide (N-TiO

methodsThe photocatalytic activity of glass slides coated with three types of N-TiO

resultsN-TiO

conclusionN-TiO

Indexed as

COVID-19SARS-CoV-2CatalysisCopperHumansLightNitrogenNitrogen DioxideSilverTitaniumCopperNitrogenNitrogen DioxideSilverTitaniumtitanium dioxideNitrogen-doped titanium dioxideSARS-CoV-2Viral inactivationVisible-light photocatalyst

Identifiers

PMID36913102
PMCPMC10009347
OpenAlexW4324020381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.